Publicacións en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (8)

2021

  1. Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

    npj Breast Cancer, Vol. 7, Núm. 1

  2. The ESSO core curriculum committee update on surgical oncology

    European Journal of Surgical Oncology, Vol. 47, Núm. 11, pp. e1-e30

2019

  1. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

2016

  1. Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts

    Oncotarget, Vol. 7, Núm. 42, pp. 67956-67965

2015

  1. Breast MRI: EUSOBI recommendations for women’s information

    European Radiology, Vol. 25, Núm. 12, pp. 3669-3678

2013

  1. Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: Results from the NeoALTTO phase III trial

    Annals of Oncology, Vol. 24, Núm. 8, pp. 1980-1985

  2. Management of the axilla in early breast cancer patients in the genomic era

    Annals of Oncology, Vol. 24, Núm. 5, pp. 1163-1170

  3. Re: Time to adjuvant chemotherapy for breast cancer in national comprehensive cancer network institutions

    Journal of the National Cancer Institute